The CCL22 receptor CCR4 is highly expressed on Tregs in GBM tissues, and other CD4 and CD8 cells in tumor tissues do not express this receptor, suggesting that the recruitment of Tregs in GBM may depend on the action of chemokines. The gene discussed is CD4; the disease is glioblastoma.